Health Care Commentary

Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir's price as soon as it was announced. They claim that Gilead...

If there was ever any doubt about the dangers of single-payer health care, the United Kingdom's experience with COVID-19 should settle the matter. Weeks after the pandemic's peak, the nation's government-run health system, the National Health Service, is still subjecting patients to life-threatening treatment delays. By...

The Trump administration just made it a bit easier for foreign doctors to join the fight against the coronavirus. This month, U.S. Citizenship and Immigration Services authorized foreign doctors in the Conrad 30 program to conduct telehealth visits across state lines. Previously, these doctors -- up...

After a decade-plus of disappointment, the end of Obamacare may finally come next year. The Trump administration recently filed a legal brief in support of the 18 states petitioning the U.S. Supreme Court to overturn Obamacare. The action has drawn sharp criticism, most notably from presumptive...

This week, the House of Representatives is set to vote on legislation designed to "stabilize" Obamacare. Democrats claim the plan, which extends exchange subsidies to a broader share of the population, will help more Americans afford health insurance in the midst of the pandemic and accompanying economic...

America’s biopharmaceutical industry dwarfs most other economic sectors. It’s one of our nation’s single biggest job creators, supporting close to a million positions across the country. And its products save countless lives each year. Yet for some reason, politicians in both parties seem determined to snuff...

By Henry I. Miller, M.S, M.D. and Andrew I. Fillat With the world in the grip of the COVID-19 pandemic, most of the short-term focus is now on how to avoid surges of infections and get the economy functioning so people can go back to work. Hindsight...

One of the most effective policy responses to COVID-19 thus far has not been a new government program or infusion of federal funding. Rather, it's been the deliberate effort by the Trump administration to pare back regulations impeding access to health care. That work must continue...

By Henry I. Miller, M.S., M.D. and Andrew I. Fillat ‘Metadata” might sound like something that “Star Trek‘s” Spock would oversee, but it is real and increasingly familiar, as the result of stories about wiretaps and security. The easiest-to-understand example of it is information about the time,...